By Mary Kekatos US Health Editor for Dailymail.Com
Moderna Inc has asked the U.S. Food and Drug Administration (FDA) to approve its Covid booster vaccination for all adults.
The booster is currently approved for people aged 65 and over and people at high risk due to general conditions or occupation.
The Johnson & Johnson booster is currently approved for all adults and the FDA is expected to approve the Pfizer booster this week.
If Moderna gets approved, it means all Americans 18 and over are eligible for an extra dose.
Moderna has submitted its application for approval of its COVID-19 vaccine booster to the FDA. Pictured: A Walmart pharmacist holds a vial of the Moderna vaccine, February 2021
The booster is currently only approved for people aged 65 and over and for people at high risk due to general conditions or occupation. Pictured: Diana Serlo, a retired registered nurse, administers a COVID-19 vaccine booster at Excela Norwin Square in North Huntingdon, Pennsylvania September 2021
In August, boosters were approved for immunocompromised Americans who had received either the Pfizer or Moderna vaccine after data showed they were less likely to develop high levels of antibodies after two doses.
Shortly afterwards, the White House announced that from Jan.
At the time, Moderna said the data support booster use for people aged 18 and older six months after receiving the second vaccination, citing the vaccinations’ declining effectiveness in preventing infection and the increased antibody levels provided by the third vaccination will.
But many scientists, including senior FDA officials, disagreed, arguing that the vaccines are still highly effective at preventing serious illness and death.
Unlike the Pfizer booster, which is just a third dose of the vaccine, the Moderna booster is a dose of 50 micrograms (µg) – half the dose of the original vaccine.
Previous data has shown that the booster increases neutralizing antibodies, including against the original virus and variants, including the beta and gamma variants.
The Moderna vaccine has been shown to be safe, but has been linked to an increased risk of rare heart infections or myocarditis, especially in young men.
During a meeting of the Centers for Disease Control and Prevention (CDC) advisory committee to discuss approval of booster doses for the Moderna and Johnson & Johnson shots last month, it was found that young men who had the Moderna-COVID- 19 vaccine were at higher risk of developing a rare case of heart inflammation than those who received the Pfizer BioNTech vaccine
A CDC official presented data showing that young men under 30 who received the Moderna vaccine had a slight increase in myocarditis and pericarditis cases.
The CDC found that 36.8 out of 1 million men ages 18 to 24 who received the Pfizer vaccine and 10.8 out of every million men ages 25 to 29 developed myocarditis.
Moderna recipients had higher rates of the disease, with 38.5 out of a million men aged 18 to 24 years and 17.2 out of every million men aged 25 to 29 developing the disease.
From the age of 29, the rate of heart inflammation as a side effect of the vaccination drops significantly.
American health officials have long recognized the risk of heart inflammation as a possible side effect of the Pfizer and Moderna vaccine in my young husband – with a warning from the CDC in June.
The Moderna vaccine, despite these data, is still considered safe and effective, with less than 0.01 percent of people who receive the vaccine developing myocarditis.
This is breaking news and will be updated.